Drugmakers aim big price hikes at U.S. patients, congressional report finds

By Diane Bartz WASHINGTON (Reuters) -Drugmakers have targeted the U.S. market to earn outsized profits from old medicines, according to a report released on Friday by the House Oversight Committee that highlighted Eli Lilly and Co, Novo Nordisk and San...

Related Keywords

Colorado ,United States ,Washington ,American ,A Novo Nordisk ,Amgen Enbrel ,Ahmed Aboulenein ,Carolyn Maloney ,Diane Bartz ,Eli Lilly ,Mallinckrodt Acthar ,Abbvie Humira ,Celgene Revlimid ,Industrie Copaxone ,Bristol Myers ,Amgen ,Reuters ,Novartis ,House Oversight Committee ,Pfizer ,Pfizer Inc ,Bristol Myers Squibb ,Novo Nordisk ,Chairwoman Carolyn Maloney ,Joe Biden ,Build Back Better ,Teva Pharmaceutical Industrie Copaxone ,Additional Reporting ,Bill Berkrot ,Anchorage ,North Slope ,Alaska ,He Dana Show ,Dana Loesch ,Glenn Beck ,Oe Pags ,Mark Levin ,Ichael Savage ,Ree Talk Live ,Oug Stephan ,Ashington State Cougars Football ,Eattle Seahawks Nfl Football ,Nbc News ,Bloomberg News ,Rad Sussman ,Outh Central Alaska Weather ,Orth Slope Weather ,Talk ,Alk Radio ,Ews Talk Radio ,Laskan Radio ,